VGM & ASSOCIATESHealthcare MSO

CMS Removes Non-Invasive Ventilators From Round 2021 Of The Competitive Bidding Program

Published in Member Communities on April 10, 2020

CMS announced today that due to the novel COVID-19 pandemic, the Centers for Medicare & Medicaid Services (CMS) is removing the non-invasive ventilators (NIV) product category from Round 2021 of the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program. This was the first time that NIVs were included in the Competitive Bidding Program.

Clint Geffert, President of VGM & Associates, commented on the announcement saying, "This is a great start and gets us headed in the right direction. Removing NIVs from the Competitive Bidding Program helps maintain access to critical, complex equipment. DME suppliers can now have peace of mind as they navigate this PHE and beyond. Thank you to everyone and their efforts over the past year to help make this happen. This was a team effort as an industry united together to listen to all of our members' needs."

Click here to read the announcement.

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

VGM Playbook: Emerging Markets and Business Growth thumbnail VGM Playbook: Emerging Markets and Business Growth Explore emerging healthcare markets, growth opportunities, and expansion strategies in pediatrics, sleep, home access, maternity care, and more. 2026 O&P Woman of the Year Finalists Announced thumbnail 2026 O&P Woman of the Year Finalists Announced Meet the 2026 O&P Woman of the Year finalists, recognized for leadership, innovation, and excellence in the orthotics and prosthetics profession. Why Signature Issues Continue to Trip Up DME Suppliers thumbnail Why Signature Issues Continue to Trip Up DME Suppliers Discover why signature-related documentation issues continue to create claim denials, audit risks, and reimbursement challenges for DME suppliers. The Fortune Is in the Follow-Up thumbnail The Fortune Is in the Follow-Up The fortune is in the follow-up. Not because follow-up is exciting. Most of the time it's not. In fact, it's often the least glamorous part of the job. But that's exactly why it creates so much value. Most people are willing to start something. Fewer people are willing to stick with it until it's finished. Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers thumbnail Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers Discover how to optimize your sleep therapy business with scalable workflows, faster therapy starts, improved adherence, and predictable revenue growth. Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers thumbnail Optimize Your Sleep Therapy Program: A Scalable, Patient-Centered Blueprint for HME Providers Discover how to optimize your sleep therapy business with scalable workflows, faster therapy starts, improved adherence, and predictable revenue growth. Adaptability Is Key to Long-Term Success in HME thumbnail Adaptability Is Key to Long-Term Success in HME Industry leader Lisa Wells shares insights on growth, payer relationships, and AI and why providers must adapt to succeed. ROI of D.C.: Understanding the Impact of CRT and HME Advocacy thumbnail ROI of D.C.: Understanding the Impact of CRT and HME Advocacy Legislation influences patient care. Learn about the importance of voting records in sustaining the CRT and HME industries.

Give your business an advantage over the competition.

Become a Member